Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALBOCICLIB vs PAMIDRONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PALBOCICLIB vs PAMIDRONATE: Safety Overview

Metric PALBOCICLIB PAMIDRONATE
Total FAERS Reports 91,024 1,639
Deaths Reported 11,066 184
Death Rate 12.2% 11.2%
Hospitalizations 13,442 484
Average Patient Age 66.0 yrs 55.1 yrs
% Female Patients 97.7% 61.6%
FDA Approval Date Feb 3, 2015 Apr 30, 2001
Manufacturer Pfizer Laboratories Div Pfizer Inc Hospira, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued